UBS Group’s Genprex GNPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.29K | Buy |
443
+239
| +117% | +$1.38K | ﹤0.01% | 10301 |
|
|
2026
Q2 | $2.33K | Buy |
+204
| New | +$3.92K | ﹤0.01% | 9367 |
|
|
2026
Q1 | – | Sell |
-4
| Closed | -$190 | – | 10374 |
|
|
2025
Q4 | $165 | Sell |
4
-143
| -97% | -$20.1K | ﹤0.01% | 10135 |
|
|
2025
Q3 | $27.4K | Buy |
147
+28
| +24% | +$7.05K | ﹤0.01% | 7955 |
|
|
2025
Q2 | $29.9K | Buy |
119
+80
| +205% | +$24.4K | ﹤0.01% | 8161 |
|
|
2025
Q1 | $10.5K | Buy |
39
+33
| +550% | +$18.3K | ﹤0.01% | 8626 |
|
|
2024
Q4 | $5.7K | Sell |
6
-45
| -88% | -$59K | ﹤0.01% | 8626 |
|
|
2024
Q3 | $20.4K | Buy |
+51
| New | +$63K | ﹤0.01% | 7364 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$2.69K | – | 9098 |
|
|
2024
Q1 | $1.76K | Hold |
1
| – | – | ﹤0.01% | 8054 |
|
|
2023
Q4 | $9.9K | Buy |
+1
| New | +$11.5K | ﹤0.01% | 7463 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7211 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7199 |
|
|
2023
Q1 | – | Sell |
-4
| Closed | -$226K | – | 7597 |
|
|
2022
Q4 | $233K | Sell |
4
-2
| -33% | -$113K | ﹤0.01% | 5340 |
|
|
2022
Q3 | $395K | Hold |
6
| – | – | ﹤0.01% | 4544 |
|
|
2022
Q2 | $378K | Hold |
6
| – | – | ﹤0.01% | 4472 |
|
|
2022
Q1 | $615K | Hold |
6
| – | – | ﹤0.01% | 4545 |
|
|
2021
Q4 | $360K | Hold |
6
| – | – | ﹤0.01% | 5238 |
|
|
2021
Q3 | $723K | Buy |
6
+3
| +100% | +$388K | ﹤0.01% | 4460 |
|
|
2021
Q2 | $380K | Hold |
3
| – | – | ﹤0.01% | 4918 |
|
|
2021
Q1 | $488K | Buy |
3
+2
| +200% | +$439K | ﹤0.01% | 4885 |
|
|
2020
Q4 | $257K | Buy |
+1
| New | +$155K | ﹤0.01% | 5084 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6580 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6223 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6720 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7656 |
|
|
2019
Q3 | – | Hold |
0
| – | -$4K | – | 8095 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7451 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7440 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 7545 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7208 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7405 |
|
Other funds holding GNPX
UBS Group's GNPX Position: Q3 2026 in Review
UBS Group increased its Genprex (GNPX) stake by 117% in Q3 2026, buying an estimated $1.38K and bringing the position to 443 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #10301.
UBS Group first reported a position in GNPX in Q4 2020 and has held it in 19 quarters since. The position peaked at $723K in Q3 2021. 16 funds tracked by Wall St. Rank hold GNPX as of Q3 2026.
- UBS Group held 443 shares of Genprex worth $1.29K as of Q3 2026.
- UBS Group bought 239 Genprex shares in Q3 2026, an estimated $1.38K.
- Genprex made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10301 holding.
- UBS Group first reported a position in Genprex in Q4 2020 and has held it in 19 quarters since.
- UBS Group's Genprex position peaked at $723K in Q3 2021.
- 16 funds tracked by Wall St. Rank held Genprex as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.